These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 31024562

  • 1. Chronic HIV-1 Infection Alters the Cellular Distribution of FcγRIIIa and the Functional Consequence of the FcγRIIIa-F158V Variant.
    Phaahla NG, Lassaunière R, Da Costa Dias B, Waja Z, Martinson NA, Tiemessen CT.
    Front Immunol; 2019; 10():735. PubMed ID: 31024562
    [Abstract] [Full Text] [Related]

  • 2. Terminal Effector CD8 T Cells Defined by an IKZF2+IL-7R- Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity.
    Naluyima P, Lal KG, Costanzo MC, Kijak GH, Gonzalez VD, Blom K, Eller LA, Creegan M, Hong T, Kim D, Quinn TC, Björkström NK, Ljunggren HG, Serwadda D, Katabira ET, Sewankambo NK, Gray RH, Baeten JM, Michael NL, Wabwire-Mangen F, Robb ML, Bolton DL, Sandberg JK, Eller MA.
    J Immunol; 2019 Oct 15; 203(8):2210-2221. PubMed ID: 31519862
    [Abstract] [Full Text] [Related]

  • 3. FcγRIIIa receptor polymorphism influences NK cell mediated ADCC activity against HIV.
    Talathi SP, Shaikh NN, Pandey SS, Saxena VA, Mamulwar MS, Thakar MR.
    BMC Infect Dis; 2019 Dec 16; 19(1):1053. PubMed ID: 31842762
    [Abstract] [Full Text] [Related]

  • 4. Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.
    Jia M, Li D, He X, Zhao Y, Peng H, Ma P, Hong K, Liang H, Shao Y.
    Clin Exp Immunol; 2013 Jan 16; 171(1):107-16. PubMed ID: 23199330
    [Abstract] [Full Text] [Related]

  • 5. Characterization of FcγRIIIA effector cells used in in vitro ADCC bioassay: Comparison of primary NK cells with engineered NK-92 and Jurkat T cells.
    Hsieh YT, Aggarwal P, Cirelli D, Gu L, Surowy T, Mozier NM.
    J Immunol Methods; 2017 Feb 16; 441():56-66. PubMed ID: 27939300
    [Abstract] [Full Text] [Related]

  • 6. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.
    Dall'Ozzo S, Tartas S, Paintaud G, Cartron G, Colombat P, Bardos P, Watier H, Thibault G.
    Cancer Res; 2004 Jul 01; 64(13):4664-9. PubMed ID: 15231679
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.
    Niwa R, Hatanaka S, Shoji-Hosaka E, Sakurada M, Kobayashi Y, Uehara A, Yokoi H, Nakamura K, Shitara K.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6248-55. PubMed ID: 15448014
    [Abstract] [Full Text] [Related]

  • 8. The influence of NK cell-mediated ADCC: Structure and expression of the CD16 molecule differ among FcγRIIIa-V158F genotypes in healthy Japanese subjects.
    Oboshi W, Watanabe T, Matsuyama Y, Kobara A, Yukimasa N, Ueno I, Aki K, Tada T, Hosoi E.
    Hum Immunol; 2016 Feb 15; 77(2):165-71. PubMed ID: 26582002
    [Abstract] [Full Text] [Related]

  • 9. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
    Tarazona R, DelaRosa O, Casado JG, Torre-Cisneros J, Villanueva JL, Galiani MD, Peña J, Solana R.
    AIDS; 2002 Jan 25; 16(2):197-200. PubMed ID: 11807303
    [Abstract] [Full Text] [Related]

  • 10. SNPs rs4656317 and rs12071048 located within an enhancer in FCGR3A are in strong linkage disequilibrium with rs396991 and influence NK cell-mediated ADCC by transcriptional regulation.
    Oboshi W, Watanabe T, Yukimasa N, Ueno I, Aki K, Tada T, Hosoi E.
    Hum Immunol; 2016 Oct 25; 77(10):997-1003. PubMed ID: 27338556
    [Abstract] [Full Text] [Related]

  • 11. Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity.
    Robinson JI, Md Yusof MY, Davies V, Wild D, Morgan M, Taylor JC, El-Sherbiny Y, Morris DL, Liu L, Rawstron AC, Buch MH, Plant D, Cordell HJ, Isaacs JD, Bruce IN, Emery P, Barton A, Vyse TJ, Barrett JH, Vital EM, Morgan AW, MATURA Consortia, MASTERPLANS Consortia.
    EBioMedicine; 2022 Dec 25; 86():104343. PubMed ID: 36371989
    [Abstract] [Full Text] [Related]

  • 12. Anti-CD20 rituximab IgG1, IgG3, and IgG4 but not IgG2 subclass trigger Ca2+ mobilization and cytotoxicity in human NK cells.
    Freitas Monteiro M, Papaserafeim M, Réal A, Puga Yung GL, Seebach JD.
    J Leukoc Biol; 2020 Oct 25; 108(4):1409-1423. PubMed ID: 32620047
    [Abstract] [Full Text] [Related]

  • 13. Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection.
    Fan X, Zhu L, Liang H, Xie Z, Huang X, Wang S, Shen T.
    Retrovirology; 2016 Nov 04; 13(1):76. PubMed ID: 27814766
    [Abstract] [Full Text] [Related]

  • 14. Comparing high-throughput methods to measure NK cell-mediated antibody dependent cellular cytotoxicity during HIV-infection.
    Konstantinus IN, Gamieldien H, Mkhize NN, Kriek JM, Passmore JA.
    J Immunol Methods; 2016 Jul 04; 434():46-52. PubMed ID: 27094485
    [Abstract] [Full Text] [Related]

  • 15. Deficient IL-2 Produced by Activated CD56+ T Cells Contributes to Impaired NK Cell-Mediated ADCC Function in Chronic HIV-1 Infection.
    Xie Z, Zheng J, Wang Y, Li D, Maermaer T, Li Y, Tu J, Xu Q, Liang H, Cai W, Shen T.
    Front Immunol; 2019 Jul 04; 10():1647. PubMed ID: 31379845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity.
    Lichtfuss GF, Meehan AC, Cheng WJ, Cameron PU, Lewin SR, Crowe SM, Jaworowski A.
    J Leukoc Biol; 2011 Jan 04; 89(1):149-58. PubMed ID: 20884651
    [Abstract] [Full Text] [Related]

  • 18. Antibody-dependent cellular cytotoxicity and cytokine/chemokine secretion by KHYG-1 cells stably expressing FcγRIIIA.
    Kobayashi E, Motoi S, Sugiura M, Kajikawa M, Kojima S, Kohroki J, Masuho Y.
    Immunol Lett; 2014 Sep 04; 161(1):59-64. PubMed ID: 24841426
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CD56bright NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.
    Judge CJ, Kostadinova L, Sherman KE, Butt AA, Falck-Ytter Y, Funderburg NT, Landay AL, Lederman MM, Sieg SF, Sandberg JK, Anthony DD.
    J Leukoc Biol; 2017 Jul 04; 102(1):171-184. PubMed ID: 28400540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.